Bayada At Inspira, Home Health And Hospice | |
600 G Street, Suite 170, Millville, New Jersey 8332 | |
(856) 293-7909 | |
Name | Bayada At Inspira, Home Health And Hospice |
---|---|
Location | 600 G Street, Suite 170, Millville, New Jersey |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 317089 |
Ownership Type | Voluntary Non-profit - Other |
Service Area Zip Codes | 8001, 8012, 8014, 8020, 8023, 8027, 8028, 8032, 8038, 8051, 8056, 8061, 8062, 8063, 8066, 8067, 8069, 8070, 8071, 8072, 8074, 8079, 8080, 8081, 8085, 8086, 8090, 8093, 8094, 8096, 8097, 8098, 8302, 8311, 8312, 8314, 8315, 8316, 8318, 8320, 8321, 8322, 8323, 8324, 8327, 8328, 8329, 8332, 8340, 8341, 8343, 8344, 8345, 8348, 8349, 8352, 8353, 8360, 8361, 8362 |
NPI Number | 1043211071 |
Organization Name | BAYADA HOME HEALTH CARE, INC. |
Address | 1101 Wheaton Ave, Suite 170, Millville, NJ 08332 |
Phone Number | 856-293-7909 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
NPI Number | 1710340575 |
Organization Name | TRI-COUNTY HOME AND HOSPICE CARE |
Doing Business As | BAYADA AT INSPIRA, HOME HEALTH AND HOSPICE |
Address | 600 G St Ste 170, Millville, NJ 08332 |
Phone Number | 856-293-7909 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
Quality Rating: |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 70.8 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.3 | 99.6 |
How often the home health team checked patients for depression | 93.1 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 75 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 68.5 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.6 | 96.4 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 79.5 | 79.6 |
How often patients got better at getting in and out of bed | 81.9 | 81.1 |
How often patients got better at bathing | 82 | 82.3 |
How often patients’ breathing improved | 84.4 | 82.8 |
How often patients’ wounds improved or healed after an operation | 91.8 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 73.3 | 75 |
How often home health patients had to be admitted to the hospital | 16.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.4 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.8 | 94 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
The patient survey data of Bayada At Inspira, Home Health And Hospice is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
Percent of patients who reported that their home health team communicated well with them | 86 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 78 | 78 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
A researcher's voice of reason entered the national debate on "Obamacare" today when Springer Science+Business Media released The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, edited by Harry P. Selker, MD, MSPH and June S. Wasser, MA. The book's fresh perspective asserts that health policy innovation is translational research directed at improving the public's health.
The Interim Haiti Recovery Commission Co-Chairs and Board held a productive meeting in the Haitian capital on Monday, approving a slate of new reconstruction projects valued at US $255 million.
The research is part of a 20-year study by the ANU Centre for Mental Health Research called PATH Through Life and suggests a revision of long-standing views on the impact of age-related brain shrinkage.
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
› Verified 4 days ago
Bayada At Inspira, Home Health And Hospice Location: 600 G Street, Suite 170, Millville, New Jersey 8332 Ratings: Phone: (856) 293-7909 |